AARD CIK: 1774857

Aardvark Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions USD
FY24:
74.1
FY25:
112
(positive)
Change from FY24 to FY25
millions USD
FY24:
3.37
FY25:
5.30
Total assets
Change from FY24 to FY25
millions USD
FY24:
77.5
FY25:
117

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions USD
FY24:
4.93
FY25:
10.5
(negative)
Change from FY24 to FY25
millions USD
FY24:
0.47
FY25:
0
(positive)
Change from FY24 to FY25
millions USD
FY24:
−54.6
FY25:
107
Total liabilities & equity
millions USD
FY24:
–
FY25:
117

All amounts in millions USD Data sources:SEC EDGARTwelve Data